Their pipelines will always be empty.
You did the right things. Sell and buy something else.
I am sellers' dad. They'll help me.
Volume is due to their second offering. They need more money to fund their dead-end research and clinical trial. This company is a cash burner. Their pipelines will always be weak due to weak leadership and inadequate management.
I am adding shorting positions every day.
Surprised me you haven't seen institutions running for exit today. Seems to me you need more market experience or lose more money.
Good luck, everyone.